ClinicalTrials.gg
Enrolling by invitationNCT06758219Updated Apr 22, 2026

Validity and Reliability of the Turkish Form of the Knowledge Assessment Scales for Dementia and Urinary Incontinence

An observational study in Urinary Incontinence in Old Age and Dementia, sponsored by Kirsehir Ahi Evran Universitesi. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 55 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Kirsehir Ahi Evran Universitesi · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
230
Ages
55 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Dementia with a site in Turkey — 6 open to participants now, 10 under way, none of them phase 3. Dementia · Turkey.

Started
2024
with 5 others
Observational
8 of 40
4 open now
Registered
27th of 40
by date

Among the 40 studies in Dementia with a site in Turkey, this one is one of 6 that started in 2024, is one of 8 observational ones, and was the 27th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

6 of the 40 studies in Dementia with a site in Turkey are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 55 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Dementia with a site in Turkey, or all of them as a file.
02

Study summary

The primary aim of the study was to determine the Turkish version of the "Validity and Reliability of the Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People". The secondary aim of the study was to measure the knowledge level of dementia and urinary incontinence in the community-living elderly population.

03

Conditions studied

  • Urinary Incontinence in Old Age
  • Dementia

Keywords

  • Urinary Incontinence
  • Dementia
  • Validity
  • Reliability
04

Who can participate

Ages eligible
55 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study will be conducted at Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center. All patient relatives and hospital staff who meet the inclusion criteria will be included in the study. These participants will be reached through face-to-face communication or online methods (sms, e-mail), and a list of participants will be prepared and evaluations will be made.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being 55 years of age or older
  2. Knowing how to read and write
  3. Being willing to participate in the study

Exclusion criteria

Exclusion Criteria:

1. Having any chronic illness that would prevent urinary retention and dementia level

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
230 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Group

    Other: There is no intervention in the study.

Interventions

  • OtherThere is no intervention in the study.

    There is no intervention in the study.

06

What researchers measure

Primary outcomes

  1. Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People

    The scale was developed by Hui Sun et al. to assess the level of knowledge about dementia and urinary incontinence among elderly individuals living in the community. The original language of the scale is Chinese and was translated into English by the researchers. The two knowledge assessment scales for dementia and urinary incontinence consist of 12 and 8 items, respectively. The model fit indicators of both met the criteria of confirmatory factor analysis. Cronbach'sα was 0.82 and 0.70, respectively. The completion rate and completion time of the two scales were 83.51% and 4.22±1.90 minutes.

    Time frame: 20 weeks

Secondary outcomes

  1. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)

    The severity of incontinence and its impact on the quality of life of the participants will be assessed with the ICIQ-SF. The ICIQ-SF consists of 6 items that question the type and frequency of urinary incontinence and the impact of incontinence on the individual's quality of life. The total score that can be obtained from the scale varies between 0-21. An increase in the total score indicates an increase in the severity of incontinence.

    Time frame: 20 weeks

  2. Incontinence Quality of Life Questionnaire (I-QOL)

    The participants' quality of life will be assessed with the I-QOL, which was specifically developed for urinary incontinence. The I-QOL is a scale consisting of 22 items and 3 subgroups that questions thoughts such as anxiety and depression that develop due to incontinence and the reflection of these thoughts on life. The total score that can be obtained from the scale varies between 0-100, and higher scores indicate better quality of life.

    Time frame: 20 weeks

  3. Standardize Mini Mental State (SMMS)

    SMMS will be used to assess the cognitive status of the participants. SMMS is a scale consisting of 11 items and 5 subgroups that measure cognitive functions. The total score that can be obtained from the scale varies between 0-30, and it is recommended that those who score 24 and below be evaluated for dementia.

    Time frame: 20 weeks

  4. Lawton-Brody Instrumental Activities of Daily Living Scale (IADL)

    The independence of the participants in their daily living activities will be assessed with the IADL. The IADL is a scale consisting of 8 items that assess instrumental daily living activities. The total score that can be obtained from the scale varies between 0-24, and an increase in the score indicates an increase in the level of independence.

    Time frame: 20 weeks

07

Study locations

1 site
  • Kirsehir Ahi Evran University Physical Therapy and Rehabilitation Center
    Kırşehir, Merkez 40100, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Jul 2026, 19 months after the start.

Of 272 non-industry observational studies under Dementia, half reached primary completion within 74 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 202. This study's planned 19 months is below that.

Counting every sponsor, half of 294 studies reached it within 65 months; a quarter within 29 and three quarters within 188.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2024
First posted
Jan 3, 2025
StartActual
Dec 8, 2024
Primary completionEst.
Jul 10, 2026
CompletionEst.
Aug 10, 2026
Last update
Apr 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06758219
Responsible party
Atahan TURHAN (Dr. Lecturer, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Jan 3, 2025
Start date
Dec 8, 2024
Primary completion
Jul 10, 2026 (estimated)
Completion
Aug 10, 2026 (estimated)
Last update
Apr 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion